Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat

Digestive Diseases and Sciences

Volumn 55, Issue 5, 2010, Pages 1278-1285

  Koetzner, Lee ^a   Grover, Gary ^a,c   Boulet, Jamie ^a   Jacoby, Henry I ^a,b  

^a Eurofins Medinet Inc   (Germany)

^b Discovery Research Consultants   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Aloe; Ambrotose; Colitis; Dextran sulfate sodium; Plant derived polysaccharides; Rat

Indexed keywords

ADVANCED AMBROTOSE; AMBROTOSE; DEXTRAN SULFATE; POLYSACCHARIDE; TAP WATER; UNCLASSIFIED DRUG; ARABINOGALACTAN; FUCOIDIN; GALACTAN; GLYCOPROTEIN; PLANT EXTRACT; STARCH;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; COLITIS; COLON; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; FECES ANALYSIS; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SHORT COURSE THERAPY; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; COLITIS; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; GALACTANS; GLYCOPROTEINS; MALE; PLANT EXTRACTS; POLYSACCHARIDES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STARCH; STATISTICS, NONPARAMETRIC;

EID: 77953636488     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0848-7     Document Type: Article

References (27)

1. Langmead L, Feakins RM, Goldthorpe S, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 2004;19:739-747. doi:10.1111/j.1365-2036.2004.01902.x. (Pubitemid 38496639)
2. Langmead L, Makins RJ, Rampton DS. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 2004;19:521-527. doi:10.1111/j.1365-2036.2004.01874.x. (Pubitemid 38387178)
3. Robinson RR, Feirtag J, Slavin JL. Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects. J Am Coll Nutr. 2001;20:279-285.
4. Patankar MS, Oehninger S, Barnett T, Williams RL, Clark GF. A revised structure for fucoid may explain some of its biological activities. J Biol Chem. 1993;268:21770-21776.
5. Moreau NM, Champ MM, Goupry SM, et al. Resistant starch modulates in vivo colonic butyrate uptake and its oxidation in rats with dextran sulfate sodium-induced colitis. J Nutr. 2004;134:493-500.
6. Santhosh S, Anandan R, Sini TK, Mathew PT. Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats. J Gastroenterol Hepatol. 2007;22:949-953. doi:10.1111/j.1440-1746.2007.04840.x. (Pubitemid 46911023)
7. Schley PD, Field CJ. The immune-enhancing effects of dietary fibres and probiotics. Br J Nutr. 2002;87:S221-S230.
8. Sinnott RA, Ramberg J, Kirchner JM, et al. Utilization of arabinogalactan, aloe vera gel polysaccharides, and a mixed saccharide dietary supplement by human colonic bacteria in vitro. Int J Probiotics Prebiotics. 2007;2:97-104.
9. Tizard IR, Carpenter RH, McAnalley BH, Kemp MC. The biological activities of mannans and related complex carbohydrates. Mol Biother. 1989;1:290-296.
10. Lehrer RI, Kline MJ. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: The role of myeloperoxidase in resistance to Candida infection. J Clin Invest. 1969;48:1478-1488. doi:10.1172/JCI106114.
11. Guarner F. Probiotics in inflammatory bowel diseases. Br J Nutr. 2007;98:S85-S89. doi:10.1017/S0007114507832958. (Pubitemid 47543484)
12. Okayasu I, Hatakemaya S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. Novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694-702.
13. Stucchi AF, Shebani KO, Leeman SE, et al. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1298-G1306.
14. Murthy SNS, Cooper HS, Shim H, Shah S, Ibrahim SA, Sedergran MT. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 1993;38:1722-1734. doi:10.1007/BF01303184.
15. Bennett CF, Kombrust D, Henry S, et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther. 1997;280:988-1000.
16. Robinson M. Medical therapy of inflammatory bowel disease for the 21st century. Eur J Surg. 1998;582:90-98. doi:10.1080/11024159850191517.
17. Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 2006;23:341-349. doi:10.1111/j.1365-2036.2006.02761.x. (Pubitemid 43382014)
18. Grip O, Janciauskiene S, Lindgren S. Macrophages in inflammatory bowel disease. Curr Drug Targets Inflame Allergy. 2003;2:155-160. doi:10.2174/ 1568010033484179.
19. Korkina L, Suprun M, Petrova A, Mikhal'chik E, Luci A, De Luca C. The protective and healing effects of a natural antioxidant formulation based on ubiquinol and aloe vera against dextran sulfate-induced ulcerative colitis in rats. Biofactors. 2003;18:255-264. doi:10.1002/biof.5520180228.
20. Matsumoto S, Nagaoka M, Hara T, Kimura-Takagi I, Mistuyama K, Ueyama S. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells. Clin Exp Immunol. 2004;136:432-439. doi:10.1111/j.1365-2249. 2004.02462.x. (Pubitemid 38703676)
21. Suzuki A, Hanada T, Mitsuyama K, et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med. 2001;193:471-481. doi:10.1084/jem.193.4.471. (Pubitemid 32524478)
22. Moreau NM, Martin LJ, Toquet CS, et al. Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo- oligosaccharides, in dextran sulfate sodium-induced experimental colitis. Br J Nutr. 2003;90:75-85. doi:10.1079/BJN2003867. (Pubitemid 36903405)
23. Breuer RI, Buto SK, Christ ML, et al. Rectal irrigation with shortchain fatty acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci. 1991;36:185-187. doi:10.1007/BF01300754.
24. Kanauchi O, Iwanaga T, Mitsuyama K, et al. Butyrate from bacterial fermentation of germinated barley foodstuff preserves intestinal barrier function in experimental colitis in the rat model. J Gastroenterol Hepatol. 1999;14:880-888. doi:10.1046/j.1440-1746.1999.01971.x. (Pubitemid 29459797)
25. Chen JT, Chen CH, Horng CT, et al. Glucosamine sulfate inhibits proinflammatory cytokine-induced ICAM-1 production in human conjunctival cells in vitro. J Ocul Pharmacol Ther. 2006;22:402-416. doi:10.1089/jop.2006.22.402. (Pubitemid 46106478)
26. Chen JT, Liang JB, Chou CL, et al. Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci. 2006;47:664-672. doi:10.1167/iovs.05- 1008. (Pubitemid 46768396)
27. Leung MYK, Liu C, Koon JCM, Fung KP. Polysaccharide biological response modifiers. Immunol Lett. 2006;105:101-114. doi:10.1016/j.imlet.2006.01.009. (Pubitemid 43816084)